The Journal of the Association of Physicians of India · 2016
Clinical and Laboratory Profile of Hospitalized Malarial Patients: An Agra-Based Study.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deshwal Rajesh
Аннотация
OBJECTIVE: The clinical presentations and laboratory profile of malaria has been changing over the years. Therefore this study was undertaken to study the clinical profile and laboratory parameters of malarial patients.
METHODS: This prospective observational study was undertaken in military hospital with high prevalence of malaria. A total of 320 patients were studied. All patients tested positive by peripheral blood smear or rapid diagnostic test were included. Clinical presentations, hematological and biochemical parameters were noted.
RESULTS: Of the total 320 patients, 249 had P vivax, 43 had P falciparum and 28 had mixed malaria.79% patients were male. Maximum (51.56%) patients were in 21-30 age group. The mean duration of symptoms was 2.54 days in vivax to 3.03 days in mixed malaria. Fever was observed in 97.8% of patients of vivax. Thrombocytopenia was observed in 99% of all patients. Splenomegaly was noticed in 24.84% patients of vivax and 34.5% of falciparum malaria. Herpes labialis was observed in 23.64% patients of vivax and 5.94% had urticaria.
CONCLUSIONS: High index of suspicion should be maintained in picking up the diagnosis. Any patient with thrombocytopenia, leucopenia, headache, herpes labialis, pain epigastrium and urticaria deserves exclusion of malaria.
METHODS: This prospective observational study was undertaken in military hospital with high prevalence of malaria. A total of 320 patients were studied. All patients tested positive by peripheral blood smear or rapid diagnostic test were included. Clinical presentations, hematological and biochemical parameters were noted.
RESULTS: Of the total 320 patients, 249 had P vivax, 43 had P falciparum and 28 had mixed malaria.79% patients were male. Maximum (51.56%) patients were in 21-30 age group. The mean duration of symptoms was 2.54 days in vivax to 3.03 days in mixed malaria. Fever was observed in 97.8% of patients of vivax. Thrombocytopenia was observed in 99% of all patients. Splenomegaly was noticed in 24.84% patients of vivax and 34.5% of falciparum malaria. Herpes labialis was observed in 23.64% patients of vivax and 5.94% had urticaria.
CONCLUSIONS: High index of suspicion should be maintained in picking up the diagnosis. Any patient with thrombocytopenia, leucopenia, headache, herpes labialis, pain epigastrium and urticaria deserves exclusion of malaria.